M&A is approaching a record high – can it last?

Deal-making in the first quarter of 2018 hit near-record levels and the appetite for M&A shows no sign of dying down, according to our 18th Global Capital Confidence Barometer (CCB). Of the 2,500 executives surveyed globally about the 12 months ahead, more than half plan an acquisition, most (84%) expect global M&A to improve further, and nearly … More M&A is approaching a record high – can it last?

How can divesting fuel your future growth?

Digital disruption, transformational shifts in customer preferences and sector convergence are forcing companies to make bets on future technology now. The result of this focus is a significant increase in companies divesting assets to fund digital growth strategies. Those that understand how evolving technology will affect their business over the next year are three times … More How can divesting fuel your future growth?

With disruptors at the gates, how will you secure your company’s future?

What lessons does 2017 provide for setting your company’s transaction strategy in 2018? In the wake of year-end US tax legislation, conditions are ripe for a surge in life sciences M&A as business leaders weigh strategic priorities for capital allocation decisions to generate inorganic growth. Despite relatively high target valuations, M&A remains essential for growth, … More With disruptors at the gates, how will you secure your company’s future?

Merger integration in a converging world

When it comes to merger integration, convergence matters Leaders in the technology, media and entertainment, and telecommunications (TMT) sectors understand the challenge of creating long-term value from M&A, and likely are aware of a recent acquisition that failed to fully achieve pre-deal expectations. As the nature and purpose of TMT dealmaking evolves, corresponding changes to … More Merger integration in a converging world

Global medtech revenue bounces back, though focus on sustainable growth must continue

The global medical technology (medtech) industry grew by 5% in 2016, a pace last seen before the financial crisis. This strong performance was fueled by mergers and acquisition (M&A) and portfolio optimization strategies, as well as continued focus on capital efficiency and research and design (R&D) investments, according to Pulse of the industry, the 2017 … More Global medtech revenue bounces back, though focus on sustainable growth must continue

European middle-market organizations forecast their growth to outpace the eurozone over next 12 months

Read the full press release here. Business confidence is high among European middle-market organizations, despite geopolitical uncertainty within and outside Europe, demographic shifts and rapid digitization across sectors according to the EY Growth Barometer: Europe. The study reveals that almost four in ten (38%) European middle-market companies are targeting current year growth of 6% to … More European middle-market organizations forecast their growth to outpace the eurozone over next 12 months

Data privacy considerations in telecommunications M&A: do you know your risk?

Global M&A activity among telecommunications (telco) companies reflects the ongoing transformation impacting the sector in response to increasing competitive intensity, evolving consumer behaviors and disruption from so-called “over-the-top” (OTT) players, which deliver audio, video or other media over the internet without the involvement of a multiple system operator in the control or distribution of the … More Data privacy considerations in telecommunications M&A: do you know your risk?

New deal terrain is no barrier for traditional players as global M&A activity remains strong

Read more on our Global Newsroom. The global mergers and acquisitions (M&A) market remained strong during the first half of 2017, despite rising protectionist sentiment and increasing intervention in deals by governments and regulators. The outlook for the remainder of the year and beyond is positive, particularly with private equity (PE) investors returning to the … More New deal terrain is no barrier for traditional players as global M&A activity remains strong

Beyond borders: Biotechnology report 2017 – Staying the course

It was supposed to be a bad year for biotech. For this sector, the simplest of truisms has always held: what goes up must eventually come down. Markets peaked in 2015 and declined in 2016; payer pressure and US election year rhetoric weighed on the sector; drug approvals fell sharply; and biotech companies faced a … More Beyond borders: Biotechnology report 2017 – Staying the course

Global Corporate Divestment Study 2017: can divesting help you capitalize on disruption?

About this study The EY Global Corporate Divestment Study focuses on how companies should approach portfolio strategy, improve divestment execution and future-proof their remaining business amid massive market disruptions. The 2017 study results are based on more than 900 interviews with corporate executives between October and December 2016 conducted by FT Remark, the research and … More Global Corporate Divestment Study 2017: can divesting help you capitalize on disruption?